## Penicillin Resistance in S. aureus **Key Point:** The most common mechanism of penicillin resistance in S. aureus is production of β-lactamase (penicillinase), an enzyme that hydrolyzes the β-lactam ring and inactivates the antibiotic. ### Mechanism of β-Lactamase Action 1. **Enzymatic hydrolysis**: β-lactamase cleaves the amide bond in the β-lactam ring 2. **Result**: Penicillin is converted to penicilloic acid, which cannot bind penicillin-binding proteins (PBPs) 3. **Outcome**: Loss of bactericidal activity **High-Yield:** Approximately 50–80% of clinical S. aureus isolates are β-lactamase producers (penicillin-resistant). These strains remain susceptible to β-lactamase-stable antibiotics such as oxacillin, nafcillin, and amoxicillin-clavulanate. ### Why Oxacillin Remains Effective Oxacillin is a β-lactamase-resistant penicillin. Its bulky side chain sterically hinders access to the β-lactam ring, making it a poor substrate for most S. aureus β-lactamases. This is why oxacillin susceptibility testing is used to identify β-lactamase-producing strains. ### Classification of S. aureus Resistance Phenotypes | Phenotype | Mechanism | Penicillin | Oxacillin | Example | |---|---|---|---|---| | **β-Lactamase producer** | Enzymatic degradation | **R** | **S** | This case | | **MRSA (methicillin-resistant)** | Altered PBP2a | R | R | Community/hospital strains | | **Intrinsic resistance** | Low PBP affinity | R | R | Some strains | **Mnemonic:** **BETA** = **B**acterial **E**nzyme **T**hat **A**ttacks β-lactams — penicillinase is the classic S. aureus resistance mechanism. ### Clinical Significance This patient's isolate is **susceptible to oxacillin**, indicating it is a **β-lactamase-producing, methicillin-susceptible S. aureus (MSSA)**. Treatment with oxacillin, nafcillin, or amoxicillin-clavulanate is appropriate and effective. **Clinical Pearl:** The distinction between MSSA (β-lactamase producer) and MRSA (altered PBP2a) is critical for therapy selection. MSSA responds to β-lactamase-stable penicillins; MRSA requires glycopeptides (vancomycin) or newer agents (linezolid, daptomycin).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.